Standard Biotools is trading at $0.81 (+7.50%) in after-hours trading, with the move appearing aligned with a risk-on market backdrop.
- It closed at $0.75 on August 13, 2026; no fresh company-specific announcement was identified for the date.
- The latest earnings release reported $20.1 million in second-quarter revenue and an improving adjusted EBITDA loss; the Treeline merger remains in progress.
- The S&P 500 rose 0.70%, and the Nasdaq Composite gained 1.04%.